These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2024932)

  • 21. Metabolic effects of intensified insulin therapy.
    Brunetti P; Bueti A; Antonella MA; Calabrese G; Fabietti PG; Santeusanio F; Massi Benedetti M
    Exp Clin Endocrinol; 1984 Apr; 83(2):130-5. PubMed ID: 6373314
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic control in diabetic pregnancy. Variations in plasma concentrations of glucose, free fatty acids, glycerol, ketone bodies, insulin, and human chorionic somatomammotropin during the last trimester.
    Persson B; Lunell NO
    Am J Obstet Gynecol; 1975 Jul; 122(6):737-45. PubMed ID: 1155514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substrate metabolism during modest hyperinsulinemia in response to isolated hyperketonemia in insulin-dependent diabetic subjects.
    Møller N; Jørgensen JO; Møller J; Bak JF; Pørksen N; Alberti KG; Schmitz O
    Metabolism; 1990 Dec; 39(12):1309-13. PubMed ID: 2246973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of acetate on blood metabolites and glucose tolerance during haemodialysis in uraemic non-diabetic and diabetic subjects.
    Akanji AO; Sacks S
    Nephron; 1991; 57(2):137-43. PubMed ID: 2020339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of the lipolysis blocker 5-methylpyrazol-3-carbonic acid (MPC) on changes in carbohydrate and lipid metabolism induced by muscle work in insulin-requiring diabetics].
    Schulz B; Michaelis D; Neumann I; Schäfer H; Wulfert P
    Z Gesamte Inn Med; 1973 Jun; 28(12):345-50. PubMed ID: 4729261
    [No Abstract]   [Full Text] [Related]  

  • 26. The response of blood intermediary metabolite levels to 24 hours treatment with a blood glucose-controlled insulin infusion system in type 1 diabetes.
    Capaldo B; Home PD; Massi-Benedetti M; Worth R; Cook DB; Heaton A; Alberti KG
    Diabetes Res; 1984 Nov; 1(4):187-93. PubMed ID: 6397293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transient triiodothyronine deficiency. Absence of effect on basal or adrenaline-stimulated carbohydrate and lipid metabolism in man.
    Pernet A; Johnston DG; Burrin JM; Orskov H; Alberti KG
    Diabete Metab; 1982 Mar; 8(1):41-6. PubMed ID: 7047251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of subcutaneous human proinsulin on the production of 64/65 split proinsulin, glucose turnover and intermediary metabolism in non-insulin-dependent diabetic man.
    Davis SN; Piatti PM; Monti L; Brown M; Hetherington C; Antsiferov M; Sobey W; Hales CN; Orskov H; Alberti KG
    Diabetes Res Clin Pract; 1993 Feb; 19(2):103-13. PubMed ID: 8472625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The metabolic response to hyperglycaemic clamping in insulin-dependent diabetes.
    Nosadini R; Noy GA; Alberti KG; Hodson A; Orskoy H
    Diabetologia; 1981 Feb; 20(2):113-7. PubMed ID: 7009290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous subcutaneous insulin infusion fails to correct impaired basal glucose metabolism and impaired insulin sensitivity of adipocytes from patients with type 1 (insulin-dependent) diabetes.
    Pedersen O; Hjøllund E; Beck-Nielsen H; Richelsen B; Sørensen NS
    Diabetes Res; 1986 Jan; 3(1):17-23. PubMed ID: 3514067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of fructose-1,6-diphosphate treatment during glucose load on the blood levels of glucose, ATP, ribose, pyruvic acid, lactic acid, NEFA, free glycerin, triglycerides and urea].
    Marsili G; Nunziata A; Alesi A; Santarelli I
    Clin Ter; 1976 Apr; 77(1):65-75. PubMed ID: 1009736
    [No Abstract]   [Full Text] [Related]  

  • 32. [Carbohydrate infusion in internal diseases. A comparative study in metabolically healthy, liver diseased and diabetic patients. VI. Infusions of a glucose/xylitol mixture (1:1 ratio) over a 48-hour period].
    Egberts EH; Rittershofer H; Müller PH; Schmülling R; Prestele H; Horbach L; Malchow H
    Infusionsther Klin Ernahr; 1982 Apr; 9(2):92-6. PubMed ID: 7044970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normalization of hepatic glucose regulation despite systemic insulin delivery. Studies in patients with pancreatic transplantation for type 1 (insulin-dependent) diabetes mellitus.
    Wilczek H; Gunnarsson R; Felig P; Ostman J; Groth CG; Wahren J
    Diabetologia; 1991 May; 34(5):345-9. PubMed ID: 1864489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic effects of adrenaline and noradrenaline in man: studies with somatostatin.
    Pernet A; Walker M; Gill GV; Orskov H; Alberti KG; Johnston DG
    Diabete Metab; 1984 May; 10(2):98-105. PubMed ID: 6146542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship of plasma acetate with glucose and other blood intermediary metabolites in non-diabetic and diabetic subjects.
    Akanji AO; Humphreys S; Thursfield V; Hockaday TD
    Clin Chim Acta; 1989 Oct; 185(1):25-34. PubMed ID: 2620451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Determination and significance of neutral lipids, fatty acids and lipid metabolites of the blood].
    Eggstein M
    Dtsch Med J; 1968 Jan; 19(1):12-4. PubMed ID: 5728658
    [No Abstract]   [Full Text] [Related]  

  • 37. Abnormal regulation of carbohydrate metabolism in motor neurone disease.
    Krentz AJ; Williams AC; Nattrass M
    Diabetes Res; 1991 Feb; 16(2):93-9. PubMed ID: 1817811
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type I diabetes is characterized by insulin resistance not only with regard to glucose, but also to lipid and amino acid metabolism.
    Trevisan R; Nosadini R; Avogaro A; Lippe G; Duner E; Fioretto P; Deana R; Tessari P; Tiengo A; Velussi M
    J Clin Endocrinol Metab; 1986 Jun; 62(6):1155-62. PubMed ID: 3517029
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic effects of moderate alcohol intake with meals in insulin-dependent diabetics controlled by artificial endocrine pancreas (AEP) and in normal subjects.
    Avogaro A; Duner E; Marescotti C; Ferrara D; Del Prato S; Nosadini R; Tiengo A
    Metabolism; 1983 May; 32(5):463-70. PubMed ID: 6341761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of the intravenous infusion of nicotinic acid on blood concentrations of substrates, metabolites and hormones in juvenile-onset diabetes].
    Michaelis D; Hahn HJ; Michael R; Schäfer H; Knospe S; Jutzi E; Wulfert P
    Diabetologia; 1970 Dec; 6(6):550-7. PubMed ID: 4924307
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.